The Valley Desk

ArticleScience advancesPublished

Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Science advances
Published
Subject terms
Animals; Shrews; Rats; Rats, Sprague-Dawley; Disease Models, Animal; Weight Loss; Nausea; Vomiting; Receptors, Gastrointestinal Hormone; Eating; Male; Glucagon-Like Peptide 1
PubMed ID
40532005
PubMed Central ID
PMC12175907
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal